This report provides industry executives with strategically significant competitor information and analysis of the leading players in the Asia Pacific pharmaceutical market.

The report provides a worldwide strategic overview of the pharmaceutical market, including:
• Sales forecast for major product segments: ethical, OTC, generics.
• Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others.
In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies.

The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.

The report’s major objectives include:
• To establish a comprehensive, factual, annually updated and cost-effective information based on performance, capabilities, goals and strategies of the leading players in the Asia Pacific pharmaceutical market.
• To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis the leading competitors.
• To assist potential market entrants in evaluating prospective acquisition and joint venture candidates.
• To complement organizations’ internal competitor information gathering efforts with strategic analysis, data interpretation and insight.
Contains 1,353 pages and 127 tables

Table Of Contents

Table of Contents


Abbott
Executive Summary
Ownership
Business Evolution
Organization and Management
Major Facilities
Product Portfolio and Technological Know-How
Marketing Capabilities
Financial Analysis
Strengths and Weaknesses
Strategic Direction
AstraZeneca
Executive Summary
Ownership
Business Evolution
Organization and Management
Major Facilities
Product Portfolio and Technological Know-How
Marketing Capabilities
Financial Analysis
Strengths and Weaknesses
Strategic Direction
Bristol-Myers Squibb
Executive Summary
Ownership
Business Evolution
Organization and Management
Major Facilities
Product Portfolio and Technological Know-How
Marketing Capabilities
Financial Analysis
Strengths and Weaknesses
Strategic Direction
Eli Lilly
Executive Summary
Ownership
Business Evolution
Organization and Management
Major Facilities
Product Portfolio and Technological Know-How
Marketing Capabilities
Financial Analysis
Strengths and Weaknesses
Strategic DirectionGlaxoSmithKline
Executive Summary
Ownership
Business Evolution
Organization and Management
Major Facilities
Product Portfolio and Technological Know-How
Marketing Capabilities
Financial Analysis
Strengths and Weaknesses
Strategic Direction
Johnson and Johnson
Executive Summary
Ownership
Business Evolution
Organization and Management
Major Facilities
Product Portfolio and Technological Know-How
Marketing Capabilities
Financial Analysis
Strengths and Weaknesses
Strategic Direction
Merck
Executive Summary
Ownership
Business Evolution
Organization and Management
Major Facilities
Product Portfolio and Technological Know-How
Marketing Capabilities
Financial Analysis
Strengths and Weaknesses
Strategic Direction
Novartis
Executive Summary
Ownership
Business Evolution
Organization and Management
Major Facilities
Product Portfolio and Technological Know-How
Marketing Capabilities
Financial Analysis
Strengths and Weaknesses
Strategic DirectionPfizer
Executive Summary
Ownership
Business Evolution
Organization and Management
Major Facilities
Product Portfolio and Technological Know-How
Marketing Capabilities
Financial Analysis
Strengths and Weaknesses
Strategic Direction
Roche
Executive Summary
Ownership
Business Evolution
Organization and Management
Major Facilities
Product Portfolio and Technological Know-How
Marketing Capabilities
Financial Analysis
Strengths and Weaknesses
Strategic Direction
Sanofi-Aventis
Executive Summary
Ownership
Business Evolution
Organization and Management
Major Facilities
Product Portfolio and Technological Know-How
Marketing Capabilities
Financial Analysis
Strengths and Weaknesses
Strategic Direction
Wyeth
Executive Summary
Ownership
Business Evolution
Organization and Management
Major Facilities
Product Portfolio and Technological Know-How
Marketing Capabilities
Financial Analysis
Strengths and Weaknesses
Strategic DirectionList of Tables
Abbott Sales and Operating Profit Growth
Abbott Sales by Therapeutic Category/Business
Abbott Sales Growth by Therapeutic Category/business
Abbott Sales by Major Drug/Business
Abbott Sales Growth by Major Drug/Business
Abbott Sales by Major Drug/Business and Geographic Region
Abbott Sales by Geographic Region and Country
Abbott Sales Growth by Geographic Region and Country
AstraZeneca Sales and Operating Profit Growth
AstraZeneca Sales by Therapeutic Category/Business
AstraZeneca Sales Growth by Therapeutic Category/business
AstraZeneca Sales by Major Drug/Business
AstraZeneca Sales Growth by Major Drug/Business
AstraZeneca Sales by Major Drug/Business and Geographic Region
AstraZeneca Sales by Geographic Region and Country
AstraZeneca Sales Growth by Geographic Region and Country
Bristol-Myers Squibb Sales and Operating Profit Growth
Bristol-Myers Squibb Sales By Major Drug and Geographic Region
Bristol-Myers Squibb Sales Growth by Major Drug
Bristol-Myers Squibb Sales By Geographic Region
Bristol-Myers Squibb Estimated Sales Growth By Geographic Region
Historical Financials
Bristol-Myers Squibb Sales and Operating Profit growth
Bristol-Myers Squibb Sales by Major Division
Bristol-Myers Squibb Sales by Major Division and Geographic Region
Bristol-Myers Squibb Sales Growth by Major Division
Bristol-Myers Squibb Sales by Therapeutic Category
Bristol-Myers Squibb Sales by Therapeutic Category and Geographic Region
Bristol-Myers Squibb Sales Growth by Therapeutic Category
Bristol-Myers Squibb Sales by Major Drug
Bristol-Myers Squibb Sales Growth by Major Drug
Bristol-Myers Squibb Sales by Product Line
Bristol-Myers Squibb Sales Growth by Product Line
Bristol-Myers Squibb Sales by Geographic Region
Bristol-Myers Squibb Sales Growth by Geographic Region
Bristol-Myers Squibb Other Health Care Sales by Product
Bristol-Myers Squibb Sales Growth by Geographic Region
Eli Lilly Sales and Operating Profit Growth
Eli Lilly Sales by Therapeutic Category
Eli Lilly Sales Growth by Therapeutic Category
Eli Lilly Sales by Major Product
Eli Lilly Sales Growth by Major Drug
Eli Lilly Sales by Geographic Region
Eli Lilly Sales Growth by Geographic Region
Eli Lilly Sales and Operating Profit Growth
GlaxoSmithKline Sales by Business Segment
GlaxoSmithKline Sales Growth by Business Segment
GlaxoSmithKline Operating Profit and Margins by Business Segment
GlaxoSmithKline Operating Profit by Business Segment GlaxoSmithKline Sales and Operating Profit Growth
GlaxoSmithKline Sales by Major Drug
GlaxoSmithKline Sales by Drug and Geographic Region
GlaxoSmithKline Sales by Therapeutic Category
GlaxoSmithKline Sales Growth by Therapeutic Category
GlaxoSmithKline Sales by Geographic Region and Country
GlaxoSmithKline Sales Growth by Geographic Region
GlaxoSmithKline Consumer Healthcare Sales by Product Line
GlaxoSmithKline Consumer Healthcare Sales Growth By Product Line
Johnson and Johnson Sales by Geographic Region and Country
Johnson and Johnson Sales Growth by Geographic Region
Johnson and Johnson Sales by Business Segment and Geographic Region
Johnson and Johnson Sales and Operating Profit Growth
Johnson and Johnson Sales by Major Drug
Johnson and Johnson Pharmaceutical Sales Growth by Major Drug
Johnson and Johnson Consumer Segment Sales by Product Line
Johnson and Johnson Consumer Segment Sales Growth by Product Line
Merck Sales and Operating Profit Growth
Merck Sales by Geographic Region
Merck Sales Growth by Geographic Region
Merck Sales by Therapeutic Category
Merck Sales Growth by Therapeutic Category
Merck Sales by Major Drug
Merck Sales Growth by Major Drug
Merck Sales by Major Drug and Geographic Region
Novartis Sales and Operating Profit Growth
Novartis Sales by Business Segment
Novartis Sales Growth by Business Segment
Novartis Operating Profit by Business Segment
Novartis Operating Profit Growth by Business Segment
Novartis Sales by Country
Novartis Sales Growth by Country
Novartis Sales by Therapeutic Category
Novartis Sales Growth by Therapeutic Category
Novartis Sales of Top 20 Drugs
Novartis Sales Growth by Major Drug
Pfizer Sales by Division
Pfizer Sales and Operating Profit Growth
Pfizer Sales by Therapeutic Category
Pfizer Sales by Major Product
Pfizer Sales Growth by Major Product
Pfizer Sales by Geographic Region
Pfizer Sales Growth by Geographic Region
Roche Sales and Operating Profit Growth
Roche Sales by Major Division
Roche Sales Growth by Business Segment
Roche Sales by Geographic Region
Roche Sales Growth by Geographic Region
Roche Sales and Operating Profit Growth
Roche Sales by Division
Roche Operating Profit by DivisionRoche Operating Profit Growth by Division
Roche Sales by Therapeutic Category
Roche Sales of Top 20 Products
Sanofi-Aventis Sales and Operating Profit Growth
Sanofi-Aventis Sales by Business Segment
Sanofi-Aventis Sales Growth by Business Segment
Sanofi-Aventis Sales of Top 15 Drugs
Sanofi-Aventis Sales Growth of Top 15 Drugs
Sanofi-Aventis Sales of 15 Major Drugs and Geographic Region
Sanofi-Aventis Sales by Geographic Region
Sanofi-Aventis Vaccine Sales by Major Product
Wyeth Sales by Business Segment
Wyeth Sales Growth by Business Segment
Wyeth Sales and Operating Profit Growth
Wyeth Sales by Therapeutic Category
Wyeth Sales by Major Drug
Wyeth Consumer Healthcare Sales by Product
Wyeth Consumer Healthcare Sales Growth by Product

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Detailed I/E report of Carbendazim export analysis

Detailed I/E report of Carbendazim export analysis

  • $ 5 400
  • Industry report
  • July 2014
  • by CCM International Limited

Carbendazim export analysis will help clients indentify export situation of technical and formulations with exclusive research methods, to offer not only the target products' export volume, price, time, ...

Global Pediatric Drugs and Vaccines Market

Global Pediatric Drugs and Vaccines Market

  • $ 4 950
  • Industry report
  • September 2014
  • by Global Industry Analysts

This report analyzes the worldwide markets for Pediatric Drugs and Vaccines in US$ Million by the following Therapeutic Class: Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective ...

Monochloroacetic Acid (MCA) Market for Cellulosics, Agrochemicals, Surfactants, Thioglycolic Acid (TGA) and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Monochloroacetic Acid (MCA) Market for Cellulosics, Agrochemicals, Surfactants, Thioglycolic Acid (TGA) and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

  • $ 4 795
  • Industry report
  • August 2014
  • by Transparency Market Research

Monochloroacetic acid (MCA) is a halogenated derivative of acetic acid. It is used in the production of a variety of compounds and intermediates. MCA is majorly used in the production of carboxymethyl ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.